Recently, serum levels of S100A12 were found to be differently expressed between four identified AD disease clusters (see Supplemental table E2 in Ref [8]) and were reported significantly upregulated in AD patients versus healthy controls with a correlation between the S100A12 serum levels and SCORAD [52]. The gene discussed is S100A12; the disease is Alzheimer disease.